Middle East and Africa miRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Library Preparation and Consumables), Technology (Sequencing by Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO)
Market Introduction
miRNA is a small noncoding RNA molecule of 20-30 nucleotides and play an important role in gene regulation. miRNA is partially complementary to messenger RNA (mRNA) and its main function is to downregulate gene expression. Since their discovery they have emerged as vital regulators of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis.
Get more information on this report :
Market Overview and Dynamics
The Middle East and Africa miRNA sequencing and assay market is expected to reach US$ 22.00 million by 2027 from US$ 8.71 million in 2019; it is estimated to grow at a CAGR of 12.4% from 2020 to 2027. The widening application range of microRNAs and rise in funding for genomics research. However, challenges associated with the delivery, efficacy, and specificity of miRNA-based therapeutics hinder the market growth.
miRNA being involved in the process of differentiation; they play a crucial role as a useful marker in identifying cell types. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, there is extensive research being conducted to identify new miRNAs. Furthermore, discovery regarding the role of miRNAs in disease development have made miRNAs a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, the growing range of applications of miRNAs is driving the growth of the miRNA sequencing and assay market. Similarly, rise in funding of genomic research to identify new molecules to diagnose and treat diseases across Middle East and Africa, is fuelling the market growth.
Countries in the Middle East regions are experiencing serious effects of the COVID-19 pandemic. The initial phases of lockdown in various countries affected the supply of many instruments and consumables in these regions. Due to surging COVID-19 cases, demand for novel diagnostic tests is on rise in the Middle East, and research activities have resulted in higher adoption of miRNA sequencing and assay procedures in this region. Hence, the ongoing pandemic is positively impacting the miRNA sequencing and assay market in the Middle East and Africa.
Key Market Segments
The Middle East and Africa miRNA sequencing and assay market, by product, is segmented into library preparation and consumables. The consumables segment held a larger share of the market in 2019, whereas the library preparation segment is anticipated to register a higher CAGR in the market during the forecast period.
Based on technology, the Middle East and Africa miRNA sequencing and assay market is segmented into sequencing by synthesis, nanopore, and ion semiconductor sequencing. The sequencing by synthesis segment held the largest share of the market in 2019; however, the nanopore segment is expected to register the highest CAGR in the market during 2020–2027.
Based on end user, the Middle East and Africa miRNA sequencing and assay market is segmented into research institute, academia, and CROs. The research institute segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the period.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the Middle East and Africa miRNA sequencing and assay market are the the Institute for Research in Genetic Engineering and Molecular Biology (INGEBI), World Health Organization (WHO), and International Agency for Research on Cancer (IARC).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis Middle East and Africa miRNA Sequencing and Assay Market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East and Africa miRNA Sequencing and Assay Market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within Middle East and Africa miRNA Sequencing and Assay Market.
Middle East and Africa miRNA Sequencing and Assay Market Segmentation
By Product
- Library Preparation
- Consumables
By Technology
- Sequencing by Synthesis
- Nanopore
- Ion Semiconductor Sequencing
By End User
- Research Institute
- Academia
- CRO
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Company Profiles
- Illumina, Inc
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Perkin Elmer, Inc.
- Takara Bio Inc.
- New England Biolabs
- Norgen Biotek Corp
- TriLink BioTechnologies Inc.
- Lexogen GmbH
- Oxford Nanopore Technologies
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa miRNA Sequencing and Assay Market – By Product
1.3.2 Middle East and Africa miRNA Sequencing and Assay Market – By Technology
1.3.3 Middle East and Africa miRNA Sequencing and Assay Market – By End User
1.3.4 Middle East and Africa miRNA Sequencing and Assay Market – By Country
2. miRNA Sequencing and Assay Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa miRNA Sequencing and Assay – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa (MEA) – PEST Analysis
4.3 Expert Opinions
5. miRNA Sequencing and Assay Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Widening Range of MicroRNA Applications
5.1.2 Rise in Funding for Genomics Research
5.2 Market Restraints
5.2.1 Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics
5.3 Market Opportunities
5.3.1 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact analysis
6. miRNA Sequencing and Assay Market – Middle East and Africa Analysis
6.1 Middle East and Africa miRNA Sequencing and Assay Market Revenue Forecast and Analysis
7. miRNA Sequencing and Assay Market Analysis – By Product
7.1 Overview
7.2 miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
7.3 Library Preparation
7.3.1 Overview
7.3.2 Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8. miRNA Sequencing and Assay Market Analysis – By Technology
8.1 Overview
8.2 miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)
8.3 Sequencing by Synthesis
8.3.1 Overview
8.3.2 Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Nanopore
8.4.1 Overview
8.4.2 Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Ion Semiconductor Sequencing
8.5.1 Overview
8.5.2 Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9. miRNA Sequencing and Assay Market Analysis – By End User
9.1 Overview
9.2 miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)
9.3 Research Institute
9.3.1 Overview
9.3.2 Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Academia
9.4.1 Overview
9.4.2 Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Contract Research Organizations (CROs)
9.5.1 Overview
9.5.2 Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
10. miRNA Sequencing and Assay Market – Middle East and Africa Analysis
10.1 Middle East & Africa: miRNA Sequencing and Assay Market
10.1.1 Overview
10.1.2 Middle East & Africa: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
10.1.3 Saudi Arabia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Saudi Arabia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Saudi Arabia: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.3.3 Saudi Arabia miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.3.4 Saudi Arabia miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.4 UAE: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 UAE: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 UAE: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.4.3 UAE miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.4.4 UAE miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.5 South Africa: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 South Africa: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 South Africa: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.5.3 South Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.5.4 South Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 Rest of Middle East and Africa: miRNA Sequencing and Assay Market - Revenue and Forecasts to 2027 (USD Million)
10.1.6.1 Rest of Middle East and Africa: miRNA Sequencing and Assay Market - Revenue and Forecasts to 2027 (USD Million)
10.1.6.2 Rest of Middle East and Africa: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.6.3 Rest of Middle East and Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.6.4 Rest of Middle East and Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Middle East and Africa miRNA Sequencing and Assay Market
11.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Illumina, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Perkin Elmer, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Takara Bio Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 New England Biolabs
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Norgen Biotek Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TriLink BioTechnologies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lexogen GmbH
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Oxford Nanopore Technologies
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. Saudi Arabia miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 3. Saudi Arabia miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. UAE miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. UAE miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 6. UAE miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. South Africa miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. South Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. South Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Rest of Middle East and Africa miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Rest of Middle East and Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. Rest of Middle East and Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, miRNA Sequencing and Assay Market
LIST OF FIGURES
Figure 1. miRNA Sequencing and Assay Market Segmentation
Figure 2. miRNA Sequencing and Assay Market Segmentation, By Country
Figure 3. Middle East and Africa miRNA Sequencing and Assay Market Overview
Figure 4. Library Preparation Segment by Product Segment Expected to Witness Rapid Growth
Figure 5. Middle East and Africa miRNA Sequencing and Assay Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa miRNA Sequencing and Assay Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
Figure 10. Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)
Figure 13. Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)
Figure 17. Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Middle East & Africa: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)
Figure 21. Middle East & Africa: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
Figure 22. Saudi Arabia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. UAE: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. South Africa: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Rest of Middle East and Africa: miRNA Sequencing and Assay Market - Revenue and Forecasts To 2027 (USD Million)
Figure 26. Impact of COVID-19 Pandemic in Middle East & Africa Market
The List of Companies - Middle East and Africa miRNA Sequencing and Assay Market
- Illumina, Inc
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Perkin Elmer, Inc.
- Takara Bio Inc.
- New England Biolabs
- Norgen Biotek Corp
- TriLink BioTechnologies Inc.
- Lexogen GmbH
- Oxford Nanopore Technologies
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa miRNA sequencing and assay market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa miRNA sequencing and assay market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.